Skandinaviska Enskilda Banken (SEB)
GNMK

Skandinaviska Enskilda Banken (SEB)’s GenMark Diagnostics, Inc GNMK Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65,000
Closed -$1.55M – 1175
2021
Q1 		$1.55M Buy
+65,000
New +$1.21M 0.01% 730

Skandinaviska Enskilda Banken (SEB)'s GNMK Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 65,000 shares — an estimated $1.55M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.55M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 65,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.55M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s GenMark Diagnostics, Inc position peaked at $1.55M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.